Home › Kanser sa Suso › California › Newport Beach
Pag-aaral pangklinika para sa Kanser sa Suso sa Newport Beach, CA
16 pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Newport Beach (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Nagre-recruitPhase 1
- Research Site, Newport Beach
IKS014 in Advanced Solid Tumors That Express HER2
Nagre-recruitPhase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Nagre-recruitPhase 3
- Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Nagre-recruitPhase 3
- Hoag Memorial Hospital Presbyterian ( Site 0010), Newport Beach
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Nagre-recruitPhase 1
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Nagre-recruitPhase 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
Nagre-recruitPhase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Nagre-recruitPhase 3
- Hoag Memorial Hospital Presbyterian, Newport Beach
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Nagre-recruitPhase 1
- Hoag Family Cancer Institute, Newport Beach
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Nagre-recruitPhase 2/3
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
Nagre-recruitPhase 1
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Hoag Memorial Hospital Presbyterian, Newport Beach
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Nagre-recruitPhase 2
- HOAG Memorial Hospital Presbyterian, Newport Beach
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
Nagre-recruitObservasyonal na pag-aaral
- USC Norris Oncology/Hematology-Newport Beach, Newport Beach
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Nagre-recruitPhase 3
- City of Hope Newport Beach, Newport Beach
Perioperative Mindfulness Proposal
Nagre-recruit
- Hoag Memorial Hospital Presbyterian, Newport Beach
Pag-aaral para sa Kanser sa Suso sa ibang lungsod
- New York City, NY136 pag-aaral
- Houston, TX126 pag-aaral
- Boston, MA112 pag-aaral
- Nashville, TN81 pag-aaral
- Los Angeles, CA73 pag-aaral
- Edison, NJ68 pag-aaral
- St. Louis, MO64 pag-aaral
- Queens, NY64 pag-aaral
- Durham, NC64 pag-aaral
- Chicago, IL59 pag-aaral
- Philadelphia, PA56 pag-aaral
- Dallas, TX55 pag-aaral
Iba pang pag-aaral sa Newport Beach
- Non-Small Cell Lung Cancer14 pag-aaral
- Metastatic Cancer10 pag-aaral
- COPD9 pag-aaral
- Kanser sa Ovary9 pag-aaral
- Kanser ng Endometrium7 pag-aaral
- Kanser sa Baga7 pag-aaral
- Colorectal Cancer6 pag-aaral
- Kanser sa Prostate6 pag-aaral
- Triple-Negative Breast Cancer6 pag-aaral
- Kanser (lahat ng uri)6 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg5 pag-aaral
- Kanser sa Bato (Renal Cell Carcinoma)5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.